Precision Biosciences (DTIL) EBT Margin (QoQ) (2018 - 2026)
Precision Biosciences (DTIL) EBT Margin (QoQ) (2018 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Precision Biosciences | 178.85 Mn | 150.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,535.00 |
| Dec 31, 2025 | 21.27 Mn |
| Sep 30, 2025 | -8.95 Mn |
| Jun 30, 2025 | -4.98 Mn |
| Mar 31, 2025 | -6.96 Mn |
| Dec 31, 2024 | 137,703.00 |
| Sep 30, 2024 | -514,647.00 |
| Jun 30, 2024 | 4,881.00 |
| Mar 31, 2024 | 17,849.00 |
| Dec 31, 2023 | -11,387.00 |
| Sep 30, 2023 | -4,393.00 |
| Jun 30, 2023 | 9,703.00 |
| Mar 31, 2023 | -2,198.00 |
| Dec 31, 2022 | 7,723.00 |
| Sep 30, 2022 | 74,823.00 |
| Jun 30, 2022 | 9,310.00 |
| Mar 31, 2022 | -54,672.00 |
| Dec 31, 2021 | -39,317.00 |
| Sep 30, 2021 | -12,044.00 |
| Jun 30, 2021 | 14,679.00 |